Covered recipient · General Payments record
JENNIE W FEIGER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2025
$4,737.08
- Reported across 35 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $454.67 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $164.55 | 2 |
| Novo Nordisk AS | $140.44 | 3 |
| Amgen Inc. | $67.18 | 2 |
| GENZYME CORPORATION | $29.52 | 1 |
| AKEBIA THERAPEUTICS INC | $27.87 | 1 |
| Otsuka America Pharmaceutical, Inc. | $25.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $27.87 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241814895 | CMS |
| Amgen Inc. | $16.35 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229037551 | CMS |
| Amgen Inc. | $50.83 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229037558 | CMS |
| Calliditas Therapeutics US Inc. | $138.98 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235013215 | CMS |
| Calliditas Therapeutics US Inc. | $25.57 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235013217 | CMS |
| GENZYME CORPORATION | $29.52 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233691578 | CMS |
| Novo Nordisk Inc | $6.93 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188337938 | CMS |
| Novo Nordisk Inc | $34.71 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188619390 | CMS |
| Novo Nordisk Inc | $98.80 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188403842 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.11 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227692667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.